日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study

MYB 和 MYBL1 在腺样囊性癌中的重排、表达和临床意义:一项多机构研究

Marta Persson, Mattias K Andersson, Yoshitsugu Mitani, Margaret S Brandwein-Weber, Henry F Frierson Jr, Christopher Moskaluk, Isabel Fonseca, Renata Ferrarotto, Werner Boecker, Thomas Loening, Adel K El-Naggar, Göran Stenman

High SMAD7 and p-SMAD2,3 expression is associated with environmental enteropathy in children

SMAD7 和 p-SMAD2,3 的高表达与儿童环境性肠病有关

Sana Syed, Vincenzo Dinallo, Najeeha T Iqbal, Laura Di Iorio, Davide Di Fusco, Shan Guleria, Beatrice C Amadi, Kamran Sadiq, Christopher Moskaluk, S Asad Ali, Paul Kelly, Giovanni Monteleone

A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug

涎腺腺样囊性癌的多重临床前模型确定瑞戈非尼是一种潜在的治疗药物

Chen Chen, Sujata Choudhury, Darawalee Wangsa, Chamille J Lescott, Devan J Wilkins, Praathibha Sripadhan, Xuefeng Liu, Danny Wangsa, Thomas Ried, Christopher Moskaluk, Michael J Wick, Eric Glasgow, Richard Schlegel, Seema Agarwal

Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma

发现可预测三阴性乳腺癌和腺样囊性癌中 GSI 反应的生物标志物

Alexander Stoeck, Serguei Lejnine, Andrew Truong, Li Pan, Hongfang Wang, Chongzhi Zang, Jing Yuan, Chris Ware, John MacLean, Philip W Garrett-Engele, Michael Kluk, Jason Laskey, Brian B Haines, Christopher Moskaluk, Leigh Zawel, Stephen Fawell, Gary Gilliland, Theresa Zhang, Brandon E Kremer, Birgit

A functional proteomic method for biomarker discovery

用于发现生物标志物的功能蛋白质组学方法

Fred Reynolds, Nivedha Panneer, Christopher M Tutino, Michael Wu, William R Skrabal, Christopher Moskaluk, Kimberly A Kelly